To improve treatment outcomes and promote continuity of care, it may be essential for staff at different programs to share client information about treatment for mental health and substance use disorders. The resources in this section are meant to explain when programs and providers can receive and re-disclose substance use disorder treatment information and mental health information.
Resource developed by the CoE-PHI to inform Part 2 programs that it is permissible to sign consent form signatures remotely, including with e-signatures.
InfoBrief developed by the CoE-PHI highlighting student privacy protections and interplay between FERPA, 42 CFR Part 2, and HIPAA related to students' mental health or SUD treatment.
Guidance issued by OCR regarding when HIPAA permits health care providers to disclose PHI of patients receiving treatment for MH conditions. Also provides information regarding protections afforded to psychotherapy notes, a parent’s rights to access information of a minor child, applicability of Federal alcohol and drug confidentiality regulations and state laws, and the intersection of HIPAA and FERPA in school settings.